Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Calithera Biosciences Inc. (CALA $0.00)
-
Seagen Inc. (SGEN)
- Cap: $43.15B
- View SGEN Profile
- View Questions on SGEN
Q: The only similarity in these two is that they both focus on cancer. Would 5i advise for or against a new position in either one? I understand that CALA is more speculative and in trials while SGEN is more established. More than happy to take on risk with either position if initiating. Your thoughts on why each are a buy or not?
Insiders
Share Information
SEC Filings
News and Media